<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Med (Lausanne)</journal-id><journal-id journal-id-type="iso-abbrev">Front Med (Lausanne)</journal-id><journal-id journal-id-type="publisher-id">Front. Med.</journal-id><journal-title-group><journal-title>Frontiers in Medicine</journal-title></journal-title-group><issn pub-type="epub">2296-858X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7546332</article-id><article-id pub-id-type="doi">10.3389/fmed.2020.562875</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine</subject><subj-group><subject>Case Report</subject></subj-group></subj-group></article-categories><title-group><article-title>An Asymptomatic SARS-CoV-2-Infected Infant With Persistent Fecal Viral RNA Shedding in a Family Cluster: A Rare Case Report</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Shen</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Si</surname><given-names>Jiafeng</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Tang</surname><given-names>Wenqiang</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Anqi</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pan</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>An</surname><given-names>Meng</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Huawei</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Xue</surname><given-names>Shoukun</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Kunpeng</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Shuangfeng</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Wei</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="c002"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Fu</surname><given-names>Bo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/980558/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Breast and Thyroid Surgery, Liaocheng People's Hospital</institution>, <addr-line>Liaocheng</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Clinical Laboratory, Dong'e People's Hospital</institution>, <addr-line>Liaocheng</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Department of Central Laboratory, Liaocheng People's Hospital</institution>, <addr-line>Liaocheng</addr-line>, <country>China</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Clinical Laboratory, Liaocheng People's Hospital</institution>, <addr-line>Liaocheng</addr-line>, <country>China</country></aff><aff id="aff5"><sup>5</sup><institution>Department of Thoracic Breast and Thyroid Surgery, Liaocheng Infectious Disease Hospital</institution>, <addr-line>Liaocheng</addr-line>, <country>China</country></aff><aff id="aff6"><sup>6</sup><institution>Department of Breast and Thyroid Surgery, Shandong Maternal and Child Health Hospital</institution>, <addr-line>Jinan</addr-line>, <country>China</country></aff><aff id="aff7"><sup>7</sup><institution>Department of CT, Liaocheng People's Hospital</institution>, <addr-line>Liaocheng</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Jeanne Marie Fair, Los Alamos National Laboratory (DOE), United States</p></fn><fn fn-type="edited-by"><p>Reviewed by: Kelly Grace Magalhaes, University of Brasilia, Brazil; Lin Wang, University of Cambridge, United Kingdom</p></fn><corresp id="c001">*Correspondence: Bo Fu <email>fubo.22@163.com</email></corresp><corresp id="c002">Wei Liu <email>15563575558@163.com</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Infectious Diseases - Surveillance, Prevention and Treatment, a section of the journal Frontiers in Medicine</p></fn></author-notes><pub-date pub-type="epub"><day>25</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>9</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>7</volume><elocation-id>562875</elocation-id><history><date date-type="received"><day>16</day><month>5</month><year>2020</year></date><date date-type="accepted"><day>07</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Chen, Si, Tang, Zhang, Pan, An, Zhang, Xue, Wu, Chen, Zhang, Liu and Fu.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Chen, Si, Tang, Zhang, Pan, An, Zhang, Xue, Wu, Chen, Zhang, Liu and Fu</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>An outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become pandemic worldwide. A better understanding of asymptomatic infections is crucial to prevent and control this epidemic. Here, we report the epidemiological and clinical characteristics of a family cluster with SARS-CoV-2 infection. In the family cluster, a 32-year-old male (case 1) and a 53-year-old female (case 2, the mother-in-law of case 1) exhibited clinical symptoms of COVID-19, while case 1's 32-year-old wife (case 3) and their 11-month-old daughter (case 4) were both asymptomatic. Notably, case 4's nasopharyngeal swab samples was negative for nearly 80 days, and her immune system has been boosted for at least 57 days, but the fecal samples have tested positive for 100 days (May 13, 2020), suggesting SARS-CoV-2 may invade enterocytes and may exist in individuals with low antiviral immunity for a long term. This report highlights that asymptomatic infections should be managed with caution and vigilance. For SARS-CoV-2 testing of asymptomatic cases, besides the normally used nasopharyngeal swab, fecal sample testing is also needed.</p></abstract><kwd-group><kwd>SARS-CoV-2</kwd><kwd>COVID-19</kwd><kwd>asymptomatic</kwd><kwd>fecal viral RNA shedding</kwd><kwd>family cluster</kwd></kwd-group><counts><fig-count count="3"/><table-count count="1"/><equation-count count="0"/><ref-count count="10"/><page-count count="5"/><word-count count="2448"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>An outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become pandemic worldwide. Although most individuals with SARS-CoV-2 infection exhibit clinical symptoms, a few [1.2% in China (<xref rid="B1" ref-type="bibr">1</xref>)] cases do not. Mounting evidence indicates asymptomatic carriers may still be infectious (<xref rid="B2" ref-type="bibr">2</xref>&#x02013;<xref rid="B4" ref-type="bibr">4</xref>). Given that asymptomatic cases are not easily identified from the population, they are often neglected by infection prevention and control protocols, and they therefore have a greater potential transmission risk. A better understanding of asymptomatic infections is crucial to prevent and control of this epidemic. Here, we report the epidemiological and clinical characteristics of a family cluster with SARS-CoV-2 infection, notably including an 11-month-old infant with persistent fecal viral RNA shedding for 100 days until now (May 13, 2020).</p></sec><sec id="s2"><title>Case Presentation</title><p>In this family cluster, a 32-year-old male (case 1) and a 53-year-old female (case 2, the mother-in-law of case 1) exhibited clinical symptoms, while case 1's 32-year-old wife (case 3) and their 11-month-old daughter (case 4) were both asymptomatic (<xref ref-type="fig" rid="F1">Figure 1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Pedigree of the clustered SARS-Cov-2 infection cases. Arrow indicates the proband (case 1). Case 2, 3, and 4 are close contacts of case 1. Full black fills indicate the individuals with COVID-19 symptoms (case 1 and 2), while partial black fills indicate asymptomatic carriers of SARS-CoV-2 (case 3 and 4).</p></caption><graphic xlink:href="fmed-07-562875-g0001"/></fig><p>On Jan 19, 2020, case 1 (index patient) visited Wuhan (Hubei, China) for a meeting and then took a train from Wuhan on Jan 21 and arrived at Liaocheng (Shandong, China) on Jan 22 (<xref ref-type="fig" rid="F2">Figure 2</xref>). He had a fever of 37.8&#x000b0;C and a productive cough after 4 days (<xref ref-type="fig" rid="F2">Figure 2</xref> and <xref rid="T1" ref-type="table">Table 1</xref>). On Jan 28, he was taken to Dong'e People's Hospital (Liaocheng, Shandong, China) by ambulance. After pre-screening and triage, he was admitted to the Infectious Disease Unit for isolation as a suspected case. His chest computed tomogram (CT) scans showed multiple mottling and ground-glass opacities in the bilateral lung (<xref ref-type="fig" rid="F3">Figure 3A</xref>), suggesting this patient has developed to pneumonia. SARS-CoV-2 nucleic acid tests (ORF1ab and N genes) of the nasopharyngeal swab samples were positive by qRT-PCR (BioGerm, Shanghai, China). According to the instruction, the kit covers 100% of known COVID-19 sequences and has no cross-reactivity with other pathogens, and the limit of detection of the kit is 1,000 copies/mL. His clinical classification was moderate. Remission was achieved after treatment with antiviral and traditional Chinese medicine.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Timeline of the cases exposed to SARS-CoV-2.</p></caption><graphic xlink:href="fmed-07-562875-g0002"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Epidemiological and clinical characteristics of the family-clustered cases with SARS-CoV-2 infection.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Characteristics</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Case 1</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Case 2</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Case 3</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Case 4</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Age</td><td valign="top" align="center" rowspan="1" colspan="1">32 years</td><td valign="top" align="center" rowspan="1" colspan="1">53 years</td><td valign="top" align="center" rowspan="1" colspan="1">32 years</td><td valign="top" align="center" rowspan="1" colspan="1">11 months</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Gender</td><td valign="top" align="center" rowspan="1" colspan="1">Male</td><td valign="top" align="center" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">Female</td><td valign="top" align="center" rowspan="1" colspan="1">Female</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>Symptoms at admission</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fever</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0221a;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0221a;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chills</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cough</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0221a;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0221a;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sore throat</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rhinorrhea</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Diarrhea</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>Chest CT scan</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mottling and ground-glass opacity</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0221a;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0221a;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>Blood analysis</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Leukocytes (&#x000d7;10<sup>9</sup>/L; normal range 5&#x02013;12)</td><td valign="top" align="center" rowspan="1" colspan="1">4.85</td><td valign="top" align="center" rowspan="1" colspan="1">6.46</td><td valign="top" align="center" rowspan="1" colspan="1">7.00</td><td valign="top" align="center" rowspan="1" colspan="1">11.35</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Neutrophils (&#x000d7;10<sup>9</sup>/L; normal range 1.8&#x02013;6.3)</td><td valign="top" align="center" rowspan="1" colspan="1">3.07</td><td valign="top" align="center" rowspan="1" colspan="1">4.74</td><td valign="top" align="center" rowspan="1" colspan="1">4.56</td><td valign="top" align="center" rowspan="1" colspan="1">1.33</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lymphocytes (&#x000d7;10<sup>9</sup>/L; normal range 1.1&#x02013;3.2)</td><td valign="top" align="center" rowspan="1" colspan="1">1.37</td><td valign="top" align="center" rowspan="1" colspan="1">1.30</td><td valign="top" align="center" rowspan="1" colspan="1">1.88</td><td valign="top" align="center" rowspan="1" colspan="1">9.27</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">CRP (mg/L; normal range 0&#x02013;10)</td><td valign="top" align="center" rowspan="1" colspan="1">10.90</td><td valign="top" align="center" rowspan="1" colspan="1">22.70</td><td valign="top" align="center" rowspan="1" colspan="1">0.50</td><td valign="top" align="center" rowspan="1" colspan="1">3.00</td></tr><tr><td valign="top" align="left" colspan="5" rowspan="1"><bold>Antibody of respiratory pathogen test</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Influenza A</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Influenza B</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Parainfluenza</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Respiratory syncytial virus</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Adenovirus</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mycoplasma pneumoniae</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Chlamydia pneumoniae</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Legionella pneumophila</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td><td valign="top" align="center" rowspan="1" colspan="1">&#x000d7;</td></tr></tbody></table><table-wrap-foot><p><italic>&#x0221a;, with; &#x000d7;, without; CRP, C-reactive protein</italic>.</p></table-wrap-foot></table-wrap><fig id="F3" position="float"><label>Figure 3</label><caption><p>Chest CT images of the four family-clustered cases. <bold>(A)</bold> Case 1. <bold>(B)</bold> Case 2. <bold>(C)</bold> Case 3. <bold>(D)</bold> Case 4.</p></caption><graphic xlink:href="fmed-07-562875-g0003"/></fig><p>Case 2 was a close contact of case 1 from Jan 22 to 26, and afterwards she developed to a fever of 38.9&#x000b0;C and cough (<xref ref-type="fig" rid="F2">Figure 2</xref>). On Feb 1, she visited the hospital for diagnosis and treatment. Her chest CT showed multiple inflammatory changes and bronchitis in the bilateral lung (<xref ref-type="fig" rid="F3">Figure 3B</xref>). Her nasopharyngeal swab sample was detected with positive SARS-CoV-2 RNA. She was classified as a moderate case. After antiviral treatment and supplement of albumin and human immunoglobulin, her symptoms were gradually relieved. After two consecutive negative SARS-CoV-2 nucleic acid tests of nasopharyngeal swabs with 24 h interval, case 1 and 2 were discharged on Feb 15 (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p><p>As close contacts of case 1 and 2, case 3, and 4 visited the Fever Clinic for further examination on Feb 4 (<xref ref-type="fig" rid="F2">Figure 2</xref>). Both individuals did not show any clinical symptoms, such as fever, chills, cough, sore throat, rhinorrhea, or diarrhea, and no signs of pneumonia was observed on chest CT scans (<xref rid="T1" ref-type="table">Table 1</xref> and <xref ref-type="fig" rid="F3">Figures 3C,D</xref>). However, their nasopharyngeal swab and fecal samples were both tested positive for SARS-CoV-2. On the same day, the two cases were admitted to the Infectious Disease Unit for isolation as asymptomatic cases. After 36 days of isolation and observation, case 3's nasopharyngeal swab and fecal samples turned negative for SARS-CoV-2 (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p><p>For case 4, her nasopharyngeal swab samples turned negative after 22 days of isolation, but the fecal samples have tested positive until now (100 days by May 13; <xref ref-type="fig" rid="F2">Figure 2</xref>). Repeated blood routine examination showed decreased neutrophils and elevated lymphocytes (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>), indicating a persistent viral infection. Flow cytometry showed that the counts of NK cells, B cells, and T-cell subtypes were all out of the reference ranges (<xref ref-type="supplementary-material" rid="SM1">Supplementary Table 1</xref>), indicating activated innate and adaptive immunity responses. The SARS-CoV-2 specific IgG was detectable on Mar 18 and Apr 12, indicating an active humoral immune reaction against the virus (<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B6" ref-type="bibr">6</xref>).</p></sec><sec sec-type="discussion" id="s3"><title>Discussion</title><p>The transmission concealment, symptom subjectivity and detection limitations increase the transmission risk of asymptomatic infections. In this report, case 2 and case 1 appeared symptoms of infection almost at the same time, suggesting that the infection seems to be transmitted during the incubation period of the index patient. To the best of our knowledge, case 4 represents the longest SARS-CoV-2 virus RNA shedding (100 days) in asymptomatic carriers. Although RT-PCR-based SARS-CoV-2 tests of the nasopharyngeal swab samples have turned negative for nearly 80 days, and the infant's immune system has been boosted for nearly 60 days, her fecal samples have still been SARS-CoV-2 positive.</p><p>Currently, case 4 has no respiratory symptoms; considering the negative SARS-CoV-2 of nasopharyngeal swab samples, the viruses might have been eliminated from the respiratory system. Since RNA fragments' half-life is very short (<xref rid="B7" ref-type="bibr">7</xref>), we speculate that SARS-CoV-2 viruses, rather than the RNA fragments, still exist, which is supported by the reduced neutrophils and elevated lymphocytes. As fecal samples have been constantly positive, we suspect that the viruses may be present in the gastrointestinal tract. Previous studies have shown that angiotensin-converting enzyme 2 (ACE2), a critical SARS-CoV-2 receptor (<xref rid="B8" ref-type="bibr">8</xref>), is not only expressed in the lung cells but also in the enterocytes (<xref rid="B9" ref-type="bibr">9</xref>).</p><p>Even though the enterocytes of case 4 may have viruses, she did not show any gastrointestinal symptoms, such as diarrhea, abdominal pain, nausea, or vomiting. Despite the production of IgG, the immune function of infants under 3-year-old has not been fully developed (<xref rid="B10" ref-type="bibr">10</xref>), which could be the reason for incomplete elimination of SARS-CoV-2 viruses in this case. Although carrying viruses, the body might be in an immune-tolerance stage and as such may not present related symptoms. It is still unpredictable whether and when the SARS-CoV-2 infection would turn negative in this case. It is still unknown whether SARS-CoV-2, like hepatitis B, could exist in individuals with low anti-viral immunity for a long time and who may become long-term carriers.</p><p>The infectivity, transmissibility, and epidemiology of asymptomatic carriers have not been clearly illustrated, and further knowledge is urgently needed. Nevertheless, before thorough understanding, asymptomatic infections still should be managed with caution and vigilance. According to the clinical experience management for asymptomatic carriers, here are some suggestions: (1) pay close attention to asymptomatic infections with intensive monitor and detection; (2) similar to the confirmed COVID-19 patients, asymptomatic carriers should also be isolated and observed until the nucleic acid test turns negative; (3) close contacts of asymptomatic carriers should also be screened for SARS-CoV-2 infection; and (4) for the SARS-CoV-2 nucleic acid test, besides the normally used nasopharyngeal swab, fecal sample-testing is also needed.</p></sec><sec sec-type="data-availability" id="s4"><title>Data Availability Statement</title><p>All datasets generated for this study are included in the article/<xref ref-type="supplementary-material" rid="SM1">Supplementary Material</xref>.</p></sec><sec id="s5"><title>Ethics Statement</title><p>Written informed consent was obtained from the individual(s), and minor(s)' legal guardian/next of kin, for the publication of any potentially identifiable images or data included in this article.</p></sec><sec id="s6"><title>Author Contributions</title><p>SheC, JS, WT, LP, MA, HZ, SX, and KW collected the samples and contributed to data acquisition. BF, ShuC, WZ, and WL designed the study. SheC, AZ, and BF wrote and edited the paper. All authors read and approved the final manuscript.</p></sec><sec id="s7"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>The authors gratefully acknowledge the members of Dong'e People's Hospital, Liaocheng Infectious Disease Hospital, and Liaocheng People's Hospital for their outstanding efforts in treating COVID-19 patients under the extreme conditions of SARS-CoV-2 outbreak and supporting the data.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by the National Nature Science Foundation of China (grant number 81702884), the Medicine and Health Science Technology Foundation of Shandong Province (grant numbers 2015WS0381 and 2016WS0216), and the Science Foundation of Liaocheng People's Hospital (grant number LYQN201901).</p></fn></fn-group><sec sec-type="supplementary-material" id="s8"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmed.2020.562875/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmed.2020.562875/full#supplementary-material</ext-link></p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Table_1.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Team</surname><given-names>NCPERE</given-names></name></person-group>. <article-title>The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China</article-title>. <source>Zhonghua Liu Xing Bing Xue Za Zhi.</source> (<year>2020</year>) <volume>41</volume>:<fpage>145</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.0254-6450.2020.02.003</pub-id><?supplied-pmid 32064853?><pub-id pub-id-type="pmid">32064853</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothe</surname><given-names>C</given-names></name><name><surname>Schunk</surname><given-names>M</given-names></name><name><surname>Sothmann</surname><given-names>P</given-names></name><name><surname>Bretzel</surname><given-names>G</given-names></name><name><surname>Froeschl</surname><given-names>G</given-names></name><name><surname>Wallrauch</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Transmission of 2019-nCoV infection from an asymptomatic contact in Germany</article-title>. <source>N Engl J Med.</source> (<year>2020</year>) <volume>382</volume>:<fpage>970</fpage>&#x02013;<lpage>1</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc2001468</pub-id><?supplied-pmid 32003551?><pub-id pub-id-type="pmid">32003551</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Rong</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Deng</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster</article-title>. <source>Int J Infect Dis.</source> (<year>2020</year>) <volume>94</volume>:<fpage>133</fpage>-<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.03.042</pub-id><?supplied-pmid 32247826?><pub-id pub-id-type="pmid">32247826</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Ji</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Hao</surname><given-names>J</given-names></name><name><surname>Dai</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Asymptomatic and human-to-human transmission of SARS-CoV-2 in a 2-family cluster, Xuzhou, China</article-title>. <source>Emerg Infect Dis.</source> (<year>2020</year>) <volume>26</volume>:<fpage>1626</fpage>-<lpage>8</lpage>. <pub-id pub-id-type="doi">10.3201/eid2607.200718</pub-id><?supplied-pmid 32228809?><pub-id pub-id-type="pmid">32228809</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>DAT</given-names></name><name><surname>Gao</surname><given-names>DC</given-names></name><name><surname>Zhang</surname><given-names>DS</given-names></name></person-group>. <article-title>Profile of specific antibodies to SARS-CoV-2: the first report</article-title>. <source>J Infect.</source> (<year>2020</year>) <volume>81</volume>:<fpage>147</fpage>-<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.012</pub-id><?supplied-pmid 32209385?><pub-id pub-id-type="pmid">32209385</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Long</surname><given-names>QX</given-names></name><name><surname>Liu</surname><given-names>BZ</given-names></name><name><surname>Deng</surname><given-names>HJ</given-names></name><name><surname>Wu</surname><given-names>GC</given-names></name><name><surname>Deng</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>YK</given-names></name><etal/></person-group>
<article-title>Antibody responses to SARS-CoV-2 in patients with COVID-19</article-title>. <source>Nat Med.</source> (<year>2020</year>) <volume>26</volume>:<fpage>845</fpage>-<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/s41591-020-0897-1</pub-id><pub-id pub-id-type="pmid">32350462</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baudrimont</surname><given-names>A</given-names></name><name><surname>Voegeli</surname><given-names>S</given-names></name><name><surname>Viloria</surname><given-names>EC</given-names></name><name><surname>Stritt</surname><given-names>F</given-names></name><name><surname>Lenon</surname><given-names>M</given-names></name><name><surname>Wada</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Multiplexed gene control reveals rapid mRNA turnover</article-title>. <source>Sci Adv.</source> (<year>2017</year>) <volume>3</volume>:<fpage>e1700006</fpage>. <pub-id pub-id-type="doi">10.1126/sciadv.1700006</pub-id><?supplied-pmid 28706991?><pub-id pub-id-type="pmid">28706991</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Xia</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name></person-group>. <article-title>Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2</article-title>. <source>Science.</source> (<year>2020</year>) <volume>367</volume>:<fpage>1444</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.abb2762</pub-id><?supplied-pmid 32132184?><pub-id pub-id-type="pmid">32132184</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamers</surname><given-names>MM</given-names></name><name><surname>Beumer</surname><given-names>J</given-names></name><name><surname>van der Vaart</surname><given-names>J</given-names></name><name><surname>Knoops</surname><given-names>K</given-names></name><name><surname>Puschhof</surname><given-names>J</given-names></name><name><surname>Breugem</surname><given-names>TI</given-names></name><etal/></person-group>. <article-title>SARS-CoV-2 productively infects human gut enterocytes</article-title>. <source>Science.</source> (<year>2020</year>) <volume>1</volume>:<fpage>eabc1669</fpage>. <pub-id pub-id-type="doi">10.1126/science.abc1669</pub-id><?supplied-pmid 32358202?><pub-id pub-id-type="pmid">32358202</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>E</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>R</given-names></name><name><surname>Lin</surname><given-names>Q</given-names></name><name><surname>Lai</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Existence of Th22 in children and evaluation of IL-22 + CD4 + T, Th17, and other T cell effector subsets from healthy children compared to adults</article-title>. <source>BMC Immunol.</source> (<year>2016</year>) <volume>17</volume>:<fpage>20</fpage>. <pub-id pub-id-type="doi">10.1186/s12865-016-0158-8</pub-id><?supplied-pmid 27338754?><pub-id pub-id-type="pmid">27338754</pub-id></mixed-citation></ref></ref-list><glossary><def-list><title>Abbreviations</title><def-item><term>COVID-19</term><def><p>coronavirus disease 2019</p></def></def-item><def-item><term>SARS-CoV-2</term><def><p>severe acute respiratory syndrome coronavirus 2</p></def></def-item><def-item><term>CT</term><def><p>computed tomogram</p></def></def-item><def-item><term>ACE2</term><def><p>angiotensin-converting enzyme 2.</p></def></def-item></def-list></glossary></back></article>